Urgent.News

What's breaking now, across thousands of outlets.

AI

Alcon and OpenAI make acquisitions; Tezspire's latest Phase 3 win

Alcon acquires Neurotech: The Swiss eye specialist paid $550 million upfront to acquire Neurotech Pharmaceuticals and could make additional payments if certain milestones are met. Alcon gains hold of an FDA-approved ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in AI

More from Wednesday 21 October →